Medical Oncologist, Researcher, Educator, Healthcare Advocacy & Policy expert, 30+ yr husband, father of 5, Texan, cancer center past President, opinions my own
Visited my congressional office in DC with Rep Goldman
Discussed Senior Act concerning preauthorization relief, sustaining Telehealth flexibilities, supporting cancer research funding!
Blessed to spend the day with several Oncologist across Texas in congressional offices of @SenTedCruz and @JohnCornyn and many Reps @ASCOadvocacy
Discussed Senior Act concerning preauthorization relief, sustaining Telehealth flexibilities, supporting cancer research funding!
Honored to have a great visit with Rep Julie Johnson from Dallas in DC and establish a relationship!
Discussed Senior Act concerning preauthorization relief, sustaining Telehealth flexibilities, supporting cancer research funding!
Got to reconnect with brother Pete Sessions in DC for congressional visit @ASCOadvocacy
Discussed Senior Act concerning preauthorization relief, sustaining Telehealth flexibilities, supporting cancer research funding!
Texas Society of Clinical Oncology @OSSatACCC was honored to be engaged with Robin Zon MD, FACP, FASCO @ASCOPres at our annual meeting in San Antonio
Thank you brother @PeteSessions for catching up today. Always a pleasure.
We are asking to:
1️⃣ End shortages of life saving drugs
2️⃣ Support @NIH, NCI, & @ARPA_H funding
3️⃣ Make telemedicine permanent
#ASCOAdvocacySummit
Hard working @ASCO delegation to the AMA. We were 3/3 with adoption of ASCO sponsored resolutions regarding AMA advocacy for access to clinical trials for MEDICARE advantage patients, modernizing remote digital lab access under CLIA, and managing ERISA laws with PBMs
Representing Texas @asco State Affiliates Council, with Pennsylvania representative, the great Ed Balaban, DO, good friend and years serving together at AMA HOD. Great meeting at ASCO HQ
It was a pleasure to speak on “Individualized Pathways in Oncology Treatment: Not an Oxymoron” at the Clinical Pathways Congress + Cancer Care Business Exchange in Boston
#AMAmtg#ASCO Team Cancer working on forming policy at AMA annual to bring light to Stark law restrictions affecting private practitioners, biosimilars are not interchangeable, and, as always, improving access to care and decreasing/eliminating disruptions in care due to PAs.